News & Events category:
Manchester Royal Infirmary

Cellular (T-cell) immunity against SARS-CoV-2 is likely to be present within most adults for at least six months after infection, according to research carried out at MFT.

The first UK patient has been treated in new COVID-19 research trialling the impact of an experimental arthritis drug, otilimab, on severe lung disease related to COVID-19.

A Wythenshawe Hospital patient with COVID-19 is the first Manchester University NHS Foundation Trust recruit to a clinical trial investigating the drug Anakinra to treat COVID-19.

More than 600 school children and teachers in Greater Manchester have taken part in a new voluntary coronavirus study, which is assessing the prevalence of COVID-19 in school pupils and teachers.

Our first patient has taken part in a new clinical trial investigating potential treatments for COVID-19, as part of a nationwide research effort to meet the challenge of coronavirus.

Researchers from Manchester University NHS Foundation Trust and The University of Manchester are to assess the effectiveness of tests that may give doctors COVID-19 results in minutes rather than days

Weight, blood pressure and blood fat elevations are greater in young people who develop type 2 diabetes according to scientists at the Universities of Manchester and Glasgow.

MFT has continued its contribution to the global fight against Coronavirus by enrolling patients in a ground-breaking new study of the virus.